The Friend helper murine leukemia virus (F-MuLV) induces in mice a high percentage of myeloblastic leukemias. Myeloblastic transformation is also observed after in vitro infection of long-term bone marrow cultures. To investigate the molecular events leading to the generation of myeloblastic leukemias, we first screened a panel of leukemic cells for rearrangement or amplification of known oncogenes or previously described specific integration sites. No modification of these genes was observed. Therefore, we searched for common integration sites by constructing a genomic library from a myeloblastic cell line harboring only five integrated proviruses. This library was screened with a virus-specific probe, and virus-host cellular junction fragments were subcloned. Two flanking cellular sequences corresponding to two different integrated proviruses were used to analyze additional myeloblastic leukemias. The first probe detected rearrangements in 2 of 42 myeloblastic leukemias, and the second probe detected rearrangements in 6 of 42. We demonstrated that, in each case, the rearrangement was the result of F-MuLV integration, with all proviruses in the same orientation and clustering in a region less than 3 kilobases long. The two regions, namedfim-i andfim-2, were different from 15 oncogenes tested. Rearrangements of these two regions were found in F-MuLV-induced myeloblastic leukemias but not in 20 lymphoid or erythroid leukemias induced by the same virus.
Retroviruses have been shown to induce a wide variety of neoplasms in animals. Studies with slow-acting retroviruses lacking onc genes have clearly demonstrated that tumors have a clonal origin and carry proviruses inserted in defined chromosomal domains. Provirus integration in these regions is believed to play an important role in tumor induction or progression or both. This insertional mutagenesis process was initially described for chicken B-cell neoplasias in which avian leukosis viruses (ALVs) were found near the c-myc proto-oncogene in most tumors (17, 29, 30) . Similarly, integration near c-erbB has been described for ALV-induced erythroblastosis (13) .
In other cases, these regions of frequent virus insertion are considered to be putative proto-oncogenes, transcriptionally activated as a consequence of nearby proviral insertion. A search for common proviral integration sites is therefore an effort to identify new classes of cellular oncogenes.
This strategy was first developed to study mammary carcinomas induced in mice by the murine mammary tumor virus (MMTV). Two transcriptional units, int-i and int-2, have been found to be activated after proviral insertion within a 30-kilobase (kb) region (8, 26, 27, 31) . Recently, two other chromosomal regions were characterized: int4i, involved in both mammary and kidney adenocarcinomas (14) , and int-H, associated with abnormalities in the differentiation characteristics of a preneoplastic phenotype (16) .
The induction of thymic lymphomas by Moloney murine leukemia virus (Mo-MuLV) in rats is associated with provirus integration in at least five independent cellular regions: c-myc (41); Mlvi-i, Mlvi-2, and Mlvi-3 (44) (45) (46) ; and
Mis-i (21).
In mice, Pim-i is a chromosomal region which can be transcriptionally activated in lymphomas of strains C57BL/6 and BALB/c infected by Mo-MuLV or in spontaneous * Corresponding author.
lymphomas from BALB/Mo and AKRIFu mice (6, 34) . pvt-i, first described as a chromosomal breakpoint region involved in variant 6,15 translocation in murine plasmacytomas, was later shown to be an integration domain in some T-cell lymphomas (15) . Interestingly, Mis-i and pvt-J correspond to the same chromosomal locus (47) . More recently, a novel region called Fis-J was shown to be implicated in both lymphoid and myeloid leukemias induced by a Friend MuLV (F-MuLV) in mice (38) .
Compared with other MuLVs such as Mo-MuLV, FMuLV is somewhat unusual: in vivo it induces a wide variety of leukemias, T-and B-cell lymphomas, erythroleukemias, and a high percentage of myeloblastic leukemias (48) . In vitro, we have been able to demonstrate that F-MuLV infection of bone marrow cells in long-term cultures leads to the generation of malignant myelomonocytic cells. This in vitro transformation, which is a multistep process, mimics the in vivo leukemogenesis (18, 19) .
In an effort to identify the molecular mechanisms of myeloblastic leukemogenesis, we examined whether known cellular oncogenes were involved in myeloblastic transformation and whether previously described or undescribed specific proviral integration sites were implicated in this process. In this study, we demonstrated that five oncogenes (Ha-ras, myb, mos, fps, and sis) and four integration sites described for murine leukemias (Pim-1, pvt-i, c-myc, and Fis-1) are not rearranged and that in some F-MuLV-induced myeloblastic leukemias, proviruses are integrated in two new preferential regions named fim-i and fim-2. Moreover, fim-i and fim-2 were not involved in 20 Table 1 .
Southern blot analysis of F-MuLV-induced leukemias. High-molecular-weight DNAs were extracted from normal mouse livers and from myeloblastic, erythroblastic, and lymphoid cell lines or tumors as previously described (39) . The DNAs were digested with restriction endonucleases as recommended by the manufacturer. Digested DNA samples (10 ,ug) were transferred to nylon membranes after electrophoresis and then hybridized under stringent conditions to 32P-nick-translated probes.
Probes. An F-MuLV-specific probe (E57BS) was derived from the 5' end of the env region of clone 57 (23) . This probe was used on EcoRI-digested genomic DNAs since EcoRI cuts the F-MuLV genome only once. Each integrated provirus yields one hybridizing fragment whose size is determined by the position of the first EcoRI site in the 3' neighboring cellular DNA ( Fig. 1; 39 ). The same EcoRIdigested DNAs were also tested with the MCF virus-specific probe described by Chattopadhyay et al. (2) .
A ClaI-AvaI 300-base-pair fragment of the MMTV LTR (9) generously donated by H. Richard-Foy and G. Hager was used on EcoRI-digested DNAs of myeloblastic cell lines and normal mouse liver. Pim-J (6), pvt-l (15), and Fis-l (38) were kindly provided by T. Cuypers, S. Cory, and J. Silver, respectively. Like the oncogenes v-mos, c-Ha-ras, v-fps, v-sis, v-myb, and c-myc, they were used as probes on Southern blots of F-MuLV-induced leukemias. In addition to the above-mentioned oncogenes, v-Ki-ras, N-ras, v-abl, v-fos, v-fms, v-erbA, v-erbB, and v-rafwere hybridized by a dot blot technique to the 69 recombinant bacteriophages obtained from our own library (see below). Dot blot hybridization. Phage preparations (2 ul) recovered after confluent lysis were loaded directly onto nitrocellulose filters. The filters were then processed as described for Southern hybridization (40) (12) . After in vitro packaging, 2.5 x 106 recombinant plaques were screened with the E57BS probe. Sixty-nine positive phage isolates were analyzed by restriction mapping and compared to the E57BS-hybridizing fragments of EcoRI-digested C cell line DNA. Recombinant phages containing characteristic EcoRI F-MuLV-host cellular junction fragments were purified and subcloned into plasmids for further analysis. Each subclone was tested for the presence of repetitive sequences after nick translation and hybridization to normal mouse DNA.
RESULTS
A panel of 42 F-MuLV-induced myeloblastic cell lines (from series Ml, M2, and M3 [ Table 1 ]) was analyzed by the Southern method with probes corresponding either to known oncogenes (Ha-ras, myb, mos, fps, and sis) or to preferential integration sites of proviruses described for lymphoid and myeloid murine leukemias: c-myc (5, 22) , Pim-1 (6), pvt-J (15) , and Fis-J (38) . No rearrangement was observed with these probes. As a control, EcoRI-digested DNAs of 10 F-MuLV-induced lymphoid leukemias (series L [ Table 1 ]) were hybridized with a c-myc probe; these DNAs were also digested with EcoRV and hybridized with Pim-1 and pvt-J probes. We observed a rearrangement of c-myc in 4 of 10 lymphoid leukemias and of both pvt-J and Pim-1 in one other lymphoid leukemia (Fig. 2) The sizes of the unrearranged alleles only are indicated on the left.
described for T-cell lymphomas (10) also occurs in myeloblastic leukemias.
Since no rearrangement or amplification was observed in myeloblastic leukemias, we decided to search for new integration regions of F-MuLV. For this purpose, we constructed a genomic library from a myeloblastic cell line and cloned virus-host junction fragments.
Cloning of virus-host junction fragnents. We first analyzed the pattern of F-MuLV provirus integration in a series of myeloblastic cell lines with the E57BS probe (Fig. 1A) . This probe detects a single 3.5-kb band in EcoRI-digested normal mouse DNA, which probably corresponds to endogenous viral sequences (39) . The same probe detected 5 to 15 newly acquired proviruses in EcoRI-digested DNAs of F-MuLVinduced myeloblastic leukemias.
For the construction of the genomic library, we used the C cell line, which harbors only five provirus copies other than the 3.5-kb endogenous fragment (Fig. 1B) . The EcoRI fragments which hybridized to the E57BS probe were 30, 20, 12, 8.3 , and 5.6 kb long. From the genomic library (see Materials and Methods), 69 positive recombinant plaques were analyzed by restriction mapping. Two recombinant phages, 167 and 341, corresponding to the 8.3-and 20-kb EcoRI hybridizing fragments, respectively, were analyzed in detail. Their maps are shown in Fig. 3 . A 1.5-kb PvuII fragment from clone 167 representing 3' flanking cellular sequences free of repetitive elements was subcloned. Similarly, a 0.4-kb PvuII-BstEII fragment was isolated from clone 341. These two fragments, 167-PP15 and 341-PBO4, were used as probes for further analysis (Fig. 3) .
Screening of F-MuLV-induced myeloblastic leukemias. A comparative analysis of strain (B6 x C)F1 normal liver and C cell line DNAs was undertaken using seven restriction enzymes (EcoRI, EcoRV, BamHI, HindIII, Sacl, KpnI, and PstI) and the 167-PP15 and 341-PBO4 probes.
In the C cell line, the 167-PP15 probe detected the same fragments corresponding to the germ line allele as in liver DNA and, in addition, with all enzymes tested, detected new Fig. 4B, lane c) . However, new bands were detected with all enzymes, the intensity of which was similar to the signal observed with normal cellular DNA. This suggested that the C cell line had lost the normal counterpart of the clone 341 chromosomal region but had duplicated the rearranged chromosomal region. This was supported by the fact that when we previously used the viral E57BS probe on the C cell line, we noticed that the 20-kb fragment in EcoRI digests (Fig. 1B) and an 11-kb fragment in HindIII digests were twice as intense as the other hybridizing fragments.
EcoRI, EcoRV, BamHI, and HindIII were determined to be the most useful enzymes for the screening of a panel of 42 myeloblastic leukemias. The 167-PP15 probe detected novel bands in two myeloblastic leukemias (C and H cell lines, series M3 [ Table 1 ]), and the 341-PBO4 probe detected novel bands in six myeloblastic leukemias (C, I, K, and X cell lines, series M3; BMC-7 cell line, series M2; and MH1 primary leukemia, series Ml [ Table 1] ). This is shown by the Southern blot results (Fig. 4 and Table 2 ).
The duplication of the rearranged chromosome and the loss of its normal counterpart have been described for another system (49) . This phenomenon was not frequently observed in our study since, except for the C cell line, all the cell lines showing a rearrangement retained the germ line allele.
Screening of F-MuLV-induced erythroblastic and lymphoid leukemias. To determine whether rearrangements also occurred in other F-MuLV-induced leukemias, we analyzed 10 lymphomas and 10 erythroleukemias (series E and L [ quences. Unfortunately, the number of inserted proviruses detected with the E57BS probe hampered this experiment. However, in all cases, one of the env hybridizing fragments comigrated with the expected viral-cellular junction fragment.
The use of the previously described overlapping phages (Fig. 5 ) allowed us to determine the restriction maps of the two chromosomal domains over a length of approximately 20 E H . kb (Fig. 6 ). These maps were confirmed by analysis of normal mouse DNA digested with seven enzymes (EcoRI, EcoRV, XbaI, HindIII, BamHI, SacI, and PstI) and hybridized with the five probes shown in Fig. 5 . No polymorphism was observed with ICFW, DBA/2, BALB/c, or C57BL/6 mouse DNA. The probes myc, myb, fms, fos, sis, erbA, erbB, Ki-ras, N-ras, Ha-ras, abl, raf, pvt-1, Fis-J, and Pim-1 did not hybridize with these two regions. We propose naming these two regions fim-i and fim-2 for F-MuLV integration in myeloblastic leukemias.
DISCUSSION
Genes involved in tumor initiation and progression can be activated through different mechanisms: (i) point mutation (32, 42) , (ii) translocation (11, 43) , (iii) amplification (1, 4) , and (iv) insertional mutagenesis (17, 29, 30) . In neoplasms induced by slow-acting viruses, i.e., viruses which do not carry oncogenes, insertional mutagenesis seems to be the common mechanism for activating cellular proto-oncogenes. This has been described for MMTV-induced mammary tumors (8, 26, 27, 31) , MMTV-induced renal adenocarcinomas (14) , and Mo-MuLV-or AKV-induced T-cell lymphomas (6, 22, 34) in mice, for Mo-MuLV-induced T-cell lymphomas in rats (21, 44, 45) , and for ALV-induced bursal lymphomas or erythroblastosis in chickens (13, 17, 29, 30) .
In this paper, we report that 7 of 42 F-MuLV-induced myeloblastic primary leukemias or cell lines had a provirus inserted in either of two different regions. These results clearly demonstrate that provirus insertion is not random and that integration in these regions is probably part of the tumorigenic process. However, fim-1 seems to be an integration domain rarely involved, because with two different probes covering 20 kb on the chromosome, we were able to detect a rearrangement in only 2 of 42 myeloblastic leukemias. In this study, the frequencies of alteration in the fim-1 (5%) and fim-2 (15%) regions were comparable to those of other integration sites reported for murine or rat leukemias. Changes in the Pim-J region caused by integration of predominantly MCF virus genomes were previously detected in 24 of 93 lymphomas studied (34) . pvt-J had proviral inserts in 6 of 19 T-cell lymphomas (15) . Fis-J has been shown to be involved in about 10% of myeloblastic or lymphoblastic leukemias (38) . In Mo-MuLV-induced lymphoid leukemias in rats, Mlvi-l and Mlvi-2 were involved in 45% of the tumors tested, whereas the frequency was only 10o for Mlvi-3 and 15% for c-myc (46) . Since fim-1 and fim-2 were involved, respectively, in only 5 and 15% of the myeloblastic leukemias tested and since we did not find rearrangement for Ha-ras, myb, mos, fps, sis, c-myc, Pim-1, pvt-1, or Fis-1, other loci not yet identified might play a role in oncogenesis.
The fact that two integration sites were isolated from the same tumor is not surprising. In Mo-MuLV-induced rat lymphomas, insertional events at two loci have occurred in the same population of tumor cells, and rearrangements in both Mlvi-l and Mlvi-2 due to provirus integration have been observed in 6 of 16 thymomas tested. A single thymoma carrying a rearrangement in only Mlvi-l also had a provirus integrated next to c-myc. It was concluded from these results that neither of the two events is independently sufficient for tumor induction, although a combination of the two may be (46) . Incidentally, in one Mo-MuLV-induced thymoma, three different proviruses were found integrated at three different loci: Mlvi-J, Mlvi-2, and Mlvi-3 (46) . Since two of the five integrated proviruses in the C cell line have been analyzed, we are currently studying the other virus-host junction fragments. In the work of Selten et al. (35) , it was noted that c-myc and Pim-1, which were involved in 50 and 46% of the tumors, respectively, were both implicated in 26% of the lymphomas. We also showed in this study that one F-MuLV-induced lymphoid leukemia had both Pim-1 and pvt-1 rearranged alleles, suggesting that, like Pim-1 and c-myc, Pim-J and pvt-l could cooperate in the initiation or progression or both of the tumorigenic process.
fim-1 and fim-2 are clearly distinct from the newly described F-MuLV integration site Fis-J (no cross-hybridization). Surprisingly, the Fis-l locus was not found to be rearranged in the F-MuLV-induced leukemias we have tested (42 myeloblastic, 10 erythroid, and 10 lymphoid leukemias). This apparent discrepancy could have resulted from differences in the structures of the F-MuLVs used, but this seems unlikely since it has been observed that integration sites are not specific for a given virus, as exemplified by the reticuloendotheliosis virus and ALV, which are both integrated near c-myc in avian bursal lymphomas (25) . Another explanation for the discrepancy could be the latency of tumor development. Indeed, Silver and Kozak (38) reported that Fis-l was involved in lymphoid and myeloblastic leukemias arising after a latency of 4 to 8 weeks. The F-MuLV-induced myeloblastic and lymphoid leukemias we studied were obtained after a latency of 6 to 12 months after either in vivo injection or in vitro infection of bone marrow cells. In support of this hypothesis, Selten et al. have shown that the frequency of c-myc and Pim-1 alterations in T lymphomas is related to the delay in the appearance of such leukemias (35) .
Data from other viral systems suggest that common integration regions could be specific for particular cell types. Thus, ALV has been found integrated near c-myc in B-cell lymphomas (17, 29) and near c-erbB in erythroblastosis (13) . Mo-MuLV is integrated near c-myc in T-cell lymphomas (5) and near c-myb in plasmacytoid lymphosarcomas (24) . Al- though no rearrangement in fim-1 or fim-2 was found in F-MuLV-induced lymphoid or erythroid leukemias, the number of DNAs studied was too small to give significant results and to permit the conclusion that these two loci were specific for myeloblastic leukemias.
Moreover, it has been reported that genetic background could influence the frequency of integration site involvement. For example, in mammary carcinomas, MMTV is commonly inserted near int-i in C3H mice (26, 27) but near int-2 in BR6 and GR mice (8, 31) . The amplification of MMTV proviruses in lymphoid leukemias was also shown to be mouse strain dependent (10 Whereas MCF proviruses are often integrated in Pim-1 and c-myc regions in T-cell lymphomas (34, 35) , only ecotropic F-MuLVs were found inserted in the fim-1 and fim-2 regions. This confirms previous studies which showed that MCF viruses are rarely found in myeloblastic leukemias (3, 37) .
Obviously, the position and orientation of the integrated proviruses with respect to the flanking sequences determine to a large extent which mechanism of activation is operational. The site and orientation of the proviruses differ from system to system. In ALV-induced bursal lymphomas and erythroblastosis, promoter insertion appears to be the predominant mechanism of oncogene activation (13, 17, 29, 33) . In murine T-cell lymphomas, proviral integrations near c-myc were all found upstream from the coding region, mainly in a transcriptional orientation opposite to that of c-myc, whereas the majority of the proviruses in the vicinity of Pim-1 were located near or in the 3' portion of the gene in the same transcriptional orientation (35) . In our system, the proviral integrations in the fim-1 and fim-2 regions were found in a region spanning less than 3 kb, and all were in the same 5'-to-3' orientation. But whatever the location of the cellular gene involved, the observed clustering of viral integration strongly supports the hypothesis that the transcriptionally activated gene is near this region.
We are studying these two chromosomal domains to define their structures and especially to locate coding sequences. Preliminary results show that the probes 51-EH09 (fim-1) and 341-HS18 (fim-2) hybridize with unique sequences in human DNA. This suggests an evolutionary conservation of fim-J and fim-2, which favors the idea that these two regions, which are different from the 15 oncogenes tested, are proto-oncogenes.
